Arthritis Research Canada will be hosting its annual ARThritis Soirée on Thursday, May 26 at 7pm. The Soirée will take place at the Vancouver Club, located at 915 W. Hastings Street, Vancouver. This gala will raise money for arthritis research, awareness, and advocacy. The concept behind the gala is that research has shown that art adds to one’s well-being. For many, it is a key element of managing chronic pain. Each year, the Soirée features one form of art. This year’s feature is the Art of Fencing with Olympic and World Champions.
The ARThritis Soirée is an evening designed to attract the city’s most prominent business and community leaders, philanthropists, doctors, scientists, healthcare professionals, and donors through an appreciation of art and a desire to support arthritis research.
The evening’s event will be emceed by Fred Lee, CBC, Vancouver Courier and The Province’s Man About Town. Guests can enjoy hors d’oeuvres, champagne, premium spirits and exquisite BC wines from LaStella and Le Vieux Pin wineries and indulge in legendary Joe Fortes oysters and Northern Divine Caviar.
There will be a live and silent auction, with items such as a chef’s table experience at Joe Fortes, photo sessions, paintings, and entertainment, vacation, spa and lifestyle packages. Buy your raffle ticket for a chance to win a beautiful Birk’s diamond necklace. Please note guests will have complimentary valet parking. Tickets to The 2016 ARThritis Soirée is available for $245.00 and includes complementary valet parking and a partial tax receipt. To learn more about the event, please click here.
Arthritis Research Canada would like to evaluate the effectiveness of Employment and Arthritis: Making it Work – an online eLearning program designed to help people with inflammatory arthritis stay employed. To do so, they are looking for participants to join a randomized controlled trial to evaluate the aforementioned program.
You are eligible if you meet the following requirements: Continue reading
(Cliquez sur la carte pour plus de renseignements sur les mises à jour apportées aux listes de médicaments assurés par les régimes provinciaux.)
Les listes de médicaments assurés par les régimes provinciaux, à votre disposition
Bonnes nouvelles pour les personnes atteintes d’une forme auto-immune d’arthrite au Canada !
Le comité ACE (Arthritis Consumer Experts) rend compte des toutes dernières nouvelles pour vous. Prenez connaissance des modifications importantes apportées aux listes de médicaments assurés par les régimes des provinces et de leur impact sur les Canadiennes et Canadiens aux prises avec une forme auto-immune d’arthrite. Ces modifications, qui sont abordées dans cette mise à jour, affectent directement les personnes atteintes de polyarthrite rhumatoïde (PR), de spondylarthrite ankylosante (SA), d’arthrite psoriasique (APs) et d’arthrite juvénile idiopathique (AJI). Continue reading
(Please click on the map for more information about the provincial drug formulary updates.)
The latest provincial listings, at your fingertips
Good news for people living with autoimmune arthritis in Canada!
Arthritis Consumer Experts (ACE) maps out the latest news for you: Read about the important changes to provincial drug formularies and what it means for Canadians living with autoimmune arthritis. The changes covered in this update affect people living with rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and juvenile idiopathic arthritis (JIA). Continue reading
BC PharmaCare is looking for your input on canakinumab for the treatment of systemic juvenile idiopathic arthritis (sJIA)
Canakinumab (Ilaris®) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By filling out a questionnaire on a website called Your Voice, you can provide feedback about canakinumab for the treatment of sJIA.
You can give input if you are a B.C. resident and have sJIA, a caregiver to someone with sJIA, or if your group represents people who live with sJIA.
The input is reviewed by the Drug Benefit Council, which then gives recommendations on whether a medication should be covered, and how, by BC PharmaCare. BC PharmaCare then makes a decision based on those recommendations and available resources. Policies and plans already in place also factor in the decision making process. Continue reading
A study in the Swedish Malmo Preventive Medicine Program (MPMP) found that men with low testosterone were more likely to develop rheumatoid arthritis. The study participants included 33,000 people born between 1921 and 1949. As part of the study, the participants underwent a number of tests, filled out questionnaires, and provided blood samples.
In the study, low testosterone levels are observed in both men and women with rheumatoid arthritis (RA). Further study is required to determine whether low testosterone levels are to blame for the onset of RA, or it is RA that drops the levels of testosterone. Continue reading